Mercer Global Advisors
BDSX icon

Mercer Global Advisors’s Biodesix BDSX Stock Holding History

Mercer Global Advisors’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$767 Buy
+34
New +$504 ﹤0.01% 5769

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Mercer Global Advisors's BDSX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Biodesix (BDSX) in Q2 2026: 34 shares worth $767. The stake represents ﹤0.01% of the portfolio and ranks #5769 among its holdings.

30 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Mercer Global Advisors held 34 shares of Biodesix worth $767 as of Q2 2026.
  • Biodesix was a new Mercer Global Advisors position in Q2 2026.
  • Biodesix made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5769 holding.
  • 30 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.